KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Income from Non-Controlling Interests (2017 - 2025)

Teva Pharmaceutical Industries (TEVA) has disclosed Income from Non-Controlling Interests for 8 consecutive years, with -$280.0 million as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Income from Non-Controlling Interests changed N/A year-over-year to -$280.0 million, compared with a TTM value of -$265.0 million through Mar 2024, changed N/A, and an annual FY2024 reading of -$320.0 million, down 471.43% over the prior year.
  • Income from Non-Controlling Interests was -$280.0 million for Q1 2024 at Teva Pharmaceutical Industries, down from $4.0 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $14.0 million in Q2 2021 and bottomed at -$280.0 million in Q1 2024.
  • Average Income from Non-Controlling Interests over 5 years is -$26.1 million, with a median of $7.0 million recorded in 2021.
  • The sharpest move saw Income from Non-Controlling Interests tumbled 650.0% in 2020, then soared 166.67% in 2023.
  • Year by year, Income from Non-Controlling Interests stood at $10.0 million in 2020, then decreased by 30.0% to $7.0 million in 2021, then plummeted by 57.14% to $3.0 million in 2022, then soared by 33.33% to $4.0 million in 2023, then crashed by 7100.0% to -$280.0 million in 2024.
  • Business Quant data shows Income from Non-Controlling Interests for TEVA at -$280.0 million in Q1 2024, $4.0 million in Q4 2023, and $8.0 million in Q3 2023.